Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BLRX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $0.29M down -3.33% YoY • BioLineRx is maintaining its cash runway guidance into the first half of 2027, supported by $13.1M in cash, cash equivalents, and short-term bank deposits as of June 30, 2026.
1

Price since post

Full Details

Advertisement|Remove ads.